Aigen Investment Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Aigen Investment Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-57,085	Closed	-$763K	–	1031
2023 Q3	$763K	Buy	+57,085	New	+$772K	0.14%	232
2021 Q1	–	Sell	-27,995	Closed	-$399K	–	837
2020 Q4	$399K	Buy	27,995 +6,345	+29%	+$85.4K	0.05%	456
2020 Q3	$301K	Buy	+21,650	New	+$258K	0.04%	539
2020 Q2	–	Sell	-340	Closed	-$3K	–	1205
2020 Q1	$3K	Buy	+340	New	+$2.83K	﹤0.01%	1190

Other funds holding RDY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Aigen Investment Management's RDY Position: Q4 2023 in Review

Aigen Investment Management sold out of Dr. Reddy's Laboratories (RDY) in Q4 2023, closing a stake of 57,085 shares — an estimated $763K sold.

Aigen Investment Management first reported a position in RDY in Q1 2020 and held it in 4 quarters. The position peaked at $763K in Q3 2023. 224 funds tracked by Wall St. Rank hold RDY as of Q4 2023.

Aigen Investment Management reported no remaining Dr. Reddy's Laboratories position as of Q4 2023 after selling out during the quarter.
Aigen Investment Management sold 57,085 Dr. Reddy's Laboratories shares in Q4 2023, an estimated $763K.
Aigen Investment Management first reported a position in Dr. Reddy's Laboratories in Q1 2020 and held it in 4 quarters.
Aigen Investment Management's Dr. Reddy's Laboratories position peaked at $763K in Q3 2023.
224 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2023.

Based on Aigen Investment Management's 13F filing for Q4 2023, filed 9 Feb 2024.